Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain

Journal of Psychopharmacology

Volumn 20, Issue 2, 2006, Pages 272-280

  Bull, Eleanor J ^a   Porkess, Veronica ^b   Rigby, Michael ^b   Hutson, Peter H ^b   Foen, Kevin C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA; 5 HT2A receptor; 5 hydroxytryptamine (5 HT; 14C 2 deoxyglucose autoradiography; Ecstasy); Local cerebral glucose utilization (LCGU); Nucleus accumbens; Serotonin)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DEOXYGLUCOSE; PSYCHEDELIC AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BRAIN; DRUG EFFECT; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; NUCLEUS ACCUMBENS; PREMEDICATION; RAT; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; BLOOD GLUCOSE; BRAIN; DEOXYGLUCOSE; ENERGY METABOLISM; HALLUCINOGENS; INJECTIONS, INTRAPERITONEAL; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; PREMEDICATION; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGENTS;

EID: 33746834626     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106059583     Document Type: Article

References (58)

1. Baldwin H A, Colado M I, Murray T K, De Souza R J, Green A R (1993) Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br J Pharmacol 108: 590-596
2. Bankson M G, Cunningham K A (2001) 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297: 946-952
3. Battaglia G, Yeh S Y, O'Hearn E, Molliver M E, Kuhar M J, De Souza E B (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242: 911-916
4. Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L, Bohuslavizki K H, Clausen M (2001) Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET. Nuc Med Comm 22: 889-897
5. Bull E J, Hutson P H, Fone K C (2003) Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT(2C) receptor responsivity. Neuropharmacology 44: 439-448
6. Bull E J, Hutson P H, Fone K C F (2004) Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 46: 202-210
7. Chaouloff F, Laude D, Baudrie V (1990) Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat. Eur J Pharmacol 187: 435-443
8. Dafters R I (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in rats. Psychopharmacology 114: 505-508
9. Dafters R I, Lynch E (1998) Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy') but not by fenfluramine. Psychopharmacology 138: 207-212
10. Fletcher P J, Robinson S R, Slippoy D L (2001) Pre-exposure to (±)3,4- methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology 25: 195-203
11. Fone K F, Beckett S G, Topham I A, Swettenham J, Ball M, Maddocks L (2002) Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159: 437-444
12. Garcia-Osta A, Del Rio J, Frechilla D (2004) Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rat frontal cortex but not in the hippocampus. Brain Res Mol Brain Res 126: 181-187
13. Gold L H, Hubner C B, Koob G F (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology 99: 40-47
14. Gordon C J, Watkinson W P, O'Callaghan J P, Miller D B (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38: 339-344
15. Green A R, O'Shea E, Colado M I (2004) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3-13
16. Gurtman C G, Morley K C, Li K M, Hunt G E, McGregor I S (2002) Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol 446: 89-96
17. Horan B, Gardner E L, Ashby C R (2000) Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA). Synapse 35: 160-162
18. Koob G F (1992) Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 654: 171-191
19. Lew R, Sabol K E, Chou C, Vosmer G L, Richards J, Seiden L S (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. J Pharmacol Exp Ther 276: 855-865
20. Liechti M E, Saur M R, Gamma A, Hell D, Vollenweider F X (2000) Psychological and physiological effects of MDMA ('Ecstasy') after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23: 396-404
21. McGregor I S, Clemens K J, Van Der Plasse G, Li K M, Hunt G E, Chen F, Lawrence A J (2003) Increased anxiety 3 months after brief exposure to MDMA ('Ecstasy') in rats: association with altered 5-HT transporter and receptor density. Neuropsychobiology 28: 1472-1484
22. Marston H M, Reid M E, Lawrence J A, Olverman H J, Butcher S P (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144: 67-76
23. Mayerhofer A, Kovar K A, Schmidt W J (2001) Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci Lett 308: 99-102
24. Mechan A O, O'Shea E, Elliott J M, Colado M I, Green A R (2001) A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation. Psychopharmacology 155: 413-418
25. Mechan A O, Esteban B, O'Shea E, Elliott J M, Colado M I, Green A R (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. British J Pharmacol 135: 170-180
26. Mengod G, Pompeiano M, Martinez-Mir M I, Palacios J M (1990) Localisation of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 542: 139-143
27. Moore R Y, Halaris A E, Jones B E (1978) Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 180: 417-438
28. Morgan A E, Horan B, Dewey S L, Ashby C R (1997) Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study. Eur J Pharmacol 331: R1-R3
29. Morley K C, Gallate J E, Hunt G E, Mallet P E, McGregor I S (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ('Ecstasy'). Eur J Pharmacol 433: 91-99
30. Nash J F Jr, Meltzer H Y, Gudelsky G A (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 295: 873-879
31. Obradovic T, Imel K M, White S R (1996) Methylenedioxymethamphetamine- induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine. Neuroscience 74: 469-481
32. Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R (2002) Specific neurotoxicity of chronic use of ecstasy. Tox Lett 127: 285-297
33. Paxinos G, Watson C (1997) The Rat Brain in Stereotaxic Co-ordinates, 4th edn. Academic Press, New York
34. Pazos A, Cortes R, Palacios J M (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346: 231-249
35. Pierce R C, Kalivas P W (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25: 192-216
36. Pompeiano M, Palacios J M, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23: 163-178
37. Pontieri F E, Crane A M, Seiden L S, Kleven M S, Porrino L J (1990) Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology 102: 175-182
38. Porrino L J (1993) Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology 112: 343-351
39. Porrino L J, Domer F R, Crane A M, Sokoloff L (1988) Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacol 1: 109-118
40. Porrino L J, Lucignani G, Dow-Edwards D, Sokoloff L (1984) Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res 307: 311-320
41. Quate L, McBean D E, Ritchie I M, Olverman H J, Kelly PA (2004) Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilization in the Dark Agouti rat. Psychopharmacology 173: 287-295
42. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra M G, de Wolff F A, Booij J (2002) The acute and chronic effects of MDMA ('Ecstasy') on cortical 5-HT(2A) receptors in rat and human brain. Neuropsychopharmacology 26: 387-396
43. Sabol K E, Lew R, Richards J B, Vosmer G L, Seiden L S (1996) Methylenedioxymethamphetamine- induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276: 846-854
44. Sadzot B, Baraban J M, Glennon R A, Lyon R A, Leonhardt S, Jan C R, Titeler M (1989) Hallucinogenic drug interactions at human brain 5- HT2 receptors: implications for treating LSD-induced hallucinogenesis. Psychopharmacology 98: 495-499
45. Schmidt C J, Kehne J H (1990) Neurotoxicity of MDMA: neurochemical effects. Ann N Y Acad Sci 600: 665-680
46. Schmidt C J, Levin J A, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36: 747-755
47. Schuier F, Orzi F, Suda S, Lucignani G, Kennedy C, Sokoloff L (1990) Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: effects of hyperglycemia in the rat. J Cereb Blood Flow Metab 10: 765-773
48. Shankaran M, Gudelsky G A (1999) A neurotoxic regimen of MDMA sup- presses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology 147: 66-72
49. Sharkey J, McBean D E, Kelly P A (1991) Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ('Ecstasy'). Psychopharmacology 105: 113-118
50. Sokoloff L, Reivich M, Kennedy C, Des Rosiers M H, Patlak C S, Pettigrew K D, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916
51. Stone D M, Stahl D C, Hanson G R, Gibb J W (1986) The effects of 3,4- methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128: 41-48
52. Thomas M J, Malenka R C (2003) Synaptic plasticity in the mesolimbic dopamine system. Philos Trans R Soc Lond B Biol Sci 358: 815-819
53. Titeler M, Lyon R A, Glennon R A (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94: 213-216
54. Tsai S J, Huang Y H, Chang L S, Yang Y C, Sim C B (1995) Alterations in local cerebral glucose utilization in rats after chronic amphetamine administration without subsequent challenge. Psychiatry Research 57: 65-73
55. White S R, Duffy P, Kalivas P W (1994) Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62: 41-50
56. Wilkerson G, London E D (1989) Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology 28: 1129-1138
57. Yamamoto B K, Spanos L J (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148: 195-203
58. Yan Q, Reith M E, Yan S (2000) Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine. Brain Res 863: 254-258